Results 131 to 140 of about 19,205,329 (382)

Author response: USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma

open access: gold, 2021
E. Josue Ruiz   +31 more
openalex   +1 more source

PL02.1.A DELINEATING AND TARGETING A NOVEL METABOLISM-BASED POST-TRANSLATIONAL MECHANISM REGULATING THE ABUNDANCE OF THE ‘UNDRUGGABLE’ ONCOPROTEIN C-MYC IN MEDULLOBLASTOMA [PDF]

open access: green, 2023
Emma Martell   +13 more
openalex   +1 more source

P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation [PDF]

open access: yes, 2014
Glioblastoma (GBM) is a highly lethal brain tumor presenting as one of two subtypes with distinct clinical histories and molecular profiles. The primary GBM subtype presents acutely as high-grade disease that typically harbors EGFR, Pten and Ink4a/Arf ...
Brennan, Cameron   +19 more
core   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis

open access: yesNature Communications, 2016
c-MYC oncogene is deregulated in most human tumours. Histone marks associated with transcriptionally active genes define high-affinity c-MYC targets. The mechanisms involved in their recognition by c-MYC are unknown.
Laia Richart   +6 more
semanticscholar   +1 more source

Investigation of c-Myc gene amplification in breast cancer patients and its correlation with other prognostic factors [PDF]

open access: yes, 2018
Background: Breast cancer is the most common cancer in woman. The frequency of amplification of some proto-oncogenes like c-Myc gene may be various in different populations.
Akbari, Mohammad Esmaeel   +2 more
core  

Ribosome biogenesis during skeletal muscle hypertrophy [PDF]

open access: yes, 2014
Muscle adaptation to chronic resistance exercise (RE) is the result of a cumulative effect on gene expression and protein content. Following a bout of RE, muscle protein synthesis increases and, if followed by consecutive bouts (training), protein ...
Walden, Ferdinand von
core   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

open access: yesMolecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

Anti-c-myc efficacy block EGFL7 induced prolactinoma tumorigenesis

open access: yesOpen Chemistry, 2019
Resistance to Dopamine agonists therapy is still a key factor that hinders the clinical treatment of prolactinoma. Consequently, a large number of investigations have been carried out to identify novel therapeutic targets.
Lan Xiaolei   +4 more
doaj   +1 more source

c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells

open access: yesBMC Cancer, 2011
Background The BRCA1 gene plays an important role in the maintenance of genomic stability. BRCA1 inactivation contributes to breast cancer tumorigenesis. An increasing number of transcription factors have been shown to regulate BRCA1 expression.
Huo Dezheng   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy